Gyne-Lotrimin

This page contains recent news articles, when available, and an overview of Gyne-Lotrimin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Gyne-Lotrimin
(when available)

Pharmacology and use:
Clotrimazole, an imidazole antifungal agent, is used for the treatment of infections caused by various species of pathogenic dermatophytes, yeasts, and Malassezia furfur. These include ringworm, candidiasis, and tinea infections. Betamethasone and clotrimazole are used together to treat cutaneous tinea infections. For the local treatment of oropharyngeal candidiasis and vaginal yeast infections, also used in fungal infections of the skin.

Mechanism Of Action:
Clotrimazole interacts with 14-α demethylase, a cytochrome P-450 enzyme that converts lanosterol to ergosterol, an essential component of the yeast membrane. In this way, clotrimazole inhibits ergosterol synthesis, resulting in increased cellular permeability. Clotrimazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms and the uptake of purine, impair triglyceride and/or phospholipid biosynthesis, and inhibit the movement of calcium and potassium ions across the cell membrane by blocking the ion transport pathway known as the Gardos channel.

News Articles on Clotrimazole

What Is Vaginitis? What Causes Vaginitis?  -  05 Jan 2010
Yeast infections are usually treated with an antifungal cream or suppository, such as miconazole (Monistat), clotrimazole (Gyne-Lotrimin) and tioconazole ... Medical News Today

Gyne-Lotrimin.(Drug overview)  -  Jan 22, 2007
Clotrimazole, the active ingredient in these medications, is used to treat fungal infections. In preparations for the skin, it is effective against ringworm ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Clotrimazole and Betamethasone (Topical).  -  Feb 1, 2006
Clotrimazole and betamethasone (kloe-TRIM-a-zole and bay-ta-METH-a-sone) combination is used to treat fungus infections. Clotrimazole works by killing the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Article: Vaginal treatments.(OTC BEST-SELLERS)(Illustration) - Chain ...  -  Jan 2, 2006
Lake Pharmaceuticals $2001519-13.3% K-Y Long LastingJohnson & Johnson$1460243 +238.6% Gyne Lotrimin 3 Schering-Plough $1344363+23.8% DollarDollar share ... Pay-Per-View - Chain Drug Review - HighBeam Research

Yeast Infection Medication Can WORSEN Your Medical Condition  -  Jun 27, 2008
Yeast infection medications are increasingly sought after by patients from drug manufacturers and providers. This is because yeast infection is becoming ... California Chronicle

Press Release: Schering-Plough Cites Today's Anacor Agreement as …  -  Feb 2, 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Schering-Plough Reports Financial Results for First …  -  Apr 23, 2008
Schering-Plough Reports Financial Results for First Quarter of 2008. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Schering-Plough Announces Hepatitis C Data …  -  May 18, 2007
Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: US Pharma Looking Overseas at Behind-the-Counter …  -  Mar 30, 2005
US Pharma Looking Overseas at Behind-the-Counter Option. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Novacea and Schering-Plough Enter into Worldwide …  -  May 30, 2007
Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer. from PR ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Rx-to-OTC Strategies Maximizing the Commercial …  -  Oct 7, 2008
Gyne-Lotrimin was a distant second to Ortho's Monistat in the Rx vaginal candidiasis market when Schering decided in 1988 to try for an OTC switch. ... Pay-Per-View - M2 Presswire - HighBeam Research

Schering reasserts itself with new asthma inhaler.(RX/BRANDED DRUGS …  -  May 2, 2005
Schering reasserts itself with new asthma inhaler.(RX/BRANDED DRUGS) ... find Chain Drug Review articles. KENILWORTH, NJ -- While it took nearly six years ... Pay-Per-View - Chain Drug Review - HighBeam Research

Press Release: Perrigo Confirms Patent Challenge of Monistat(R) 1 …  -  Apr 21, 2008
Perrigo Confirms Patent Challenge of Monistat(R) 1 Combination Pack. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

LET DOCTOR GIVE DIAGNOSIS  -  Nov 22, 2006
Dear Dr. Donohue: Three weeks ago I developed vaginal discharge and itching. I told a friend, and she said she had the perfect medicine for a yeast ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

Vaginal symptoms not improving with treatment  -  Nov 3, 2007
If you have symptoms of a vaginal yeast infection and have been diagnosed and treated by your health professional for this condition in the past, ... MSN Health & Fitness

Forget ComEd -- ban drug ads | Article from Chicago Sun-Times | …  -  Sep 25, 2006
Forget ComEd -- ban drug ads ... find Chicago Sun-Times articles. Everyone seems to be in an uproar over the ComEd ads telling us about price increases in ... Pay-Per-View - Chicago Sun-Times - HighBeam Research

Article: Durbach, Nadja: Bodily Matters: The Anti-vaccination...  -  Jun 22, 2005
Durbach, Nadja: Bodily Matters: The Anti-vaccination Movement in England, 1853-1907.(Book Review) ... find History: Review of New Books articles. Pay-Per-View - History: Review of New Books - HighBeam Research

Causes of a Candidacies Yeast Infection  -  Mar 15, 2008
Yeast is produced by a woman's body naturally in the rectum and vagina area. If this yeast begins to grow too rapidly, then a candidiasis yeast infection ... Buzzle

EBSCOhost Connection: Vaginal Yeast Infection.  -  Jan 1, 2005
Vaginal Yeast Infection: The article provides information about vaginal yeast infection, which is a condition caused by a yeast fungus called Candida ... Subscription - Vaginal Yeast Infection - EBSCO Publishing

Article: Taro receives OK for cream that combats yeast infections.(OT...  -  Apr 18, 2005
Taro receives OK for cream that combats yeast infections.(OT-Cs)(Brief Article) ... find Chain Drug Review articles. Taro Pharmaceutical Industries Ltd. has ... Pay-Per-View - Chain Drug Review - HighBeam Research

Ditch the itch: yeast is a fact of life. But thanks to a host of...  -  Dec 1, 2006
ALL WOMEN HAVE YEAST. It's all around us: in the air, on our skin, in our digestive tracts, and in our--well, our delicate female areas. ... Pay-Per-View - Natural Health - Factiva, from Dow Jones

Article: DEMAND RISING FOR ANTI-INFECTION DRUGS IN CHINA - …  -  May 20, 2008
DEMAND RISING FOR ANTI-INFECTION DRUGS IN CHINA ... find AsiaInfo Services articles. AsiaInfo Services 05-20-2008 Demand Rising for Anti-infection Drugs in ... Pay-Per-View - AsiaInfo Services - HighBeam Research

Yeast infection (candidiasis).(Adult Health Advisor 2007)(Disease/ …  -  May 31, 2007
A yeast infection is a condition caused by the fungus Candida albicans. It is also called candidiasis. The yeast may infect the vagina, mouth, ... $4.95 - Clinical Reference Systems - ECNext

Yeast infection (Candidiasis).(care and treatment)  -  May 24, 2006
A yeast infection is a condition caused by the fungus Candida albicans. It is also called candidiasis. The yeast may infect the vagina, mouth, ... $4.95 - Clinical Reference Systems - ECNext

Vaginal treatments.(Illustration) | Article from Chain Drug Review | ...  -  Jun 6, 2005
Gyne Lotrimin 3 3.4 mil. 0.3 mil. 8. Vagisil 2.4 mil. 0.4 mil. 9. Vagi-Gard 2.3 mil. 0.4 mil. 10. Vagistat 3 1.7 mil. 0.3 mil. ** All private label brands ... Pay-Per-View - Chain Drug Review - HighBeam Research

Yeast infection (candidiasis).(Women's Health Advisor 2006)(Disease/ …  -  Nov 1, 2006
A yeast infection is a condition caused by the fungus Candida albicans. It is also called candidiasis. The yeast may infect the vagina, mouth, ... $4.95 - Clinical Reference Systems - ECNext

Competitors by Product Report  -  Dec 27, 2008
Healthcare. Biopharmaceuticals. Endocrinology/Metabolism. Pituitary Gland Disorders. Pituitary Hyperthyroidism (TSH-Induced). Thyroid Hormones ... $75.00 - Revere - Alacra Store

HCP's business is lifestyle, nutrition, diabetes.(HealthCare Products)...  -  Jun 6, 2005
HCP's business is lifestyle, nutrition, diabetes.(HealthCare Products)(corporate profile)(Company Profile) ... find Chain Drug Review articles. Pay-Per-View - Chain Drug Review - HighBeam Research

Viêm nhiá»…m âm đạo do nấm candida  -  Jan 26, 2006
Thư�ng gặp, do một trong số nhi�u chủng nấm có tên là Candida gây ra. Nấm Candida là loại nấm vẫn có với số lượng ít trong âm đạo cũng như trong miệng và ... Báo Khoa h�c

Article: Yeast Infections; Overview. - NWHRC Health Center - Yeast …  -  May 25, 2005
Article: SCHERING-PLOUGH HEALTHCARE PRODUCTS INTRODUCES GYNE-LOTRIMIN ... PR Newswire; April 26, 1993 ; 700+ words ... ... most bothersome aspect of vaginal ... Pay-Per-View - NWHRC Health Center - Yeast Infections - HighBeam Research

Article: Yeast Infections; Facts to Know. - NWHRC Health Center -...  -  Mar 14, 2006
Yeast Infections; Facts to Know. ... find NWHRC Health Center - Yeast Infections articles. Seventy-five percent of women are likely to have at least one ... Pay-Per-View - NWHRC Health Center - Yeast Infections - HighBeam Research

Article: US Rx sales, 2005.(IMS INSIGHTS)(retail prescription drug...  -  Mar 1, 2005
Article: How Gyne-Lotrimin cleared the hurdles in entering the OTC market. ... Medical Marketing & Media; February 1, 1992 ; 700+ words . ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Brand Names/Synonyms:
Gyne-Lotrimin is also known by the following brand names and/or synonymsBAY 5097; Bay B 5097; Bay B 9057; Bay-B 5097; Canesten; Canesten Cream; Canesten Solution; Canestine; Canifug; Chlotrimazole; Clotrimaderm; Clotrimaderm Cream; Clotrimazol; Clotrimazole; Clotrimazole Crystalline; Clotrimazole Znso4 Complex; Empecid; FB 5097; Femcare; Gyne Lotrimin; Gyne-Lotrimin; Gyne-Lotrimin 3; Gyne-Lotrimin 3 Combination Pack; Gyne-Lotrimin Combination Pack; Gynix; Gynixo; Lotion; Lotrimin; Lotrimin Af; Lotrimin Af Cream; Lotrimin Af Jock-Itch Cream; Lotrimin Af Lotion; Lotrimin Af Solution; Lotrimin Cream; Lotrimin Lotion; Lotrimin Solution; Lotrisone; Mono-Baycuten; Mycelax; Mycelex; Mycelex 7; Mycelex Cream; Mycelex G; Mycelex Otc; Mycelex Solution; Mycelex Troches; Mycelex Twin Pack; Mycelex-7; Mycelex-7 Combination Pack; Mycelex-G; Myclo Cream; Myclo Solution; Myclo Spray Solution; Myclo-Gyne; Mycosporin; Mykosporin; Myofug; Neo-Zol Cream; Pack; Pedisafe; Rimazole; Therapy; Travagizole; Trimysten; Trivagizole 3; Veltrim

Drug Category:
Gyne-Lotrimin is categorized under the following by the FDA: Antifungals; Anti-Infectives; ATC:A01AB18; ATC:D01AC01; ATC:G01AF02

Dosage Forms:
creams, lotions, ointment, lozenges

Absorption:
Well absorbed orally but minimal if vaginal or topical

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
1-[(2-chlorophenyl)-diphenyl-methyl]-1H-imidazole





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy